Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Gurgaon-based ReNew Power has raised a $1-billion project loan through external commercial borrowings (ECB), tying up with 12 international banks for the finance.
EXAMIANS